BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21975465)

  • 1. Novel Clostridium perfringens enterotoxin suicide gene therapy for selective treatment of claudin-3- and -4-overexpressing tumors.
    Walther W; Petkov S; Kuvardina ON; Aumann J; Kobelt D; Fichtner I; Lemm M; Piontek J; Blasig IE; Stein U; Schlag PM
    Gene Ther; 2012 May; 19(5):494-503. PubMed ID: 21975465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy.
    Pahle J; Menzel L; Niesler N; Kobelt D; Aumann J; Rivera M; Walther W
    BMC Cancer; 2017 Feb; 17(1):129. PubMed ID: 28193196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.
    Maeda T; Murata M; Chiba H; Takasawa A; Tanaka S; Kojima T; Masumori N; Tsukamoto T; Sawada N
    Prostate; 2012 Mar; 72(4):351-60. PubMed ID: 21656836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE).
    Santin AD; Bellone S; Marizzoni M; Palmieri M; Siegel ER; McKenney JK; Hennings L; Comper F; Bandiera E; Pecorelli S
    Cancer; 2007 Apr; 109(7):1312-22. PubMed ID: 17326053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncoleaking: Use of the Pore-Forming Clostridium perfringens Enterotoxin (CPE) for Suicide Gene Therapy.
    Pahle J; Aumann J; Kobelt D; Walther W
    Methods Mol Biol; 2015; 1317():69-85. PubMed ID: 26072402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
    Santin AD; Cané S; Bellone S; Palmieri M; Siegel ER; Thomas M; Roman JJ; Burnett A; Cannon MJ; Pecorelli S
    Cancer Res; 2005 May; 65(10):4334-42. PubMed ID: 15899825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium perfringens enterotoxin as a novel-targeted therapeutic for brain metastasis.
    Kominsky SL; Tyler B; Sosnowski J; Brady K; Doucet M; Nell D; Smedley JG; McClane B; Brem H; Sukumar S
    Cancer Res; 2007 Sep; 67(17):7977-82. PubMed ID: 17804705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin.
    Piontek A; Eichner M; Zwanziger D; Beier LS; Protze J; Walther W; Theurer S; Schmid KW; Führer-Sakel D; Piontek J; Krause G
    Mol Oncol; 2020 Feb; 14(2):261-276. PubMed ID: 31825142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of a claudin-targeting molecule using a C-terminal fragment of Clostridium perfringens enterotoxin.
    Ebihara C; Kondoh M; Hasuike N; Harada M; Mizuguchi H; Horiguchi Y; Fujii M; Watanabe Y
    J Pharmacol Exp Ther; 2006 Jan; 316(1):255-60. PubMed ID: 16183701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Claudin-Targeted Suicide Gene Therapy for Claudin-Overexpressing Tumor Cells by Using Modified Clostridium perfringens Enterotoxin (CPE).
    Beier LS; Piontek J; Piontek A; Protze J; Kobelt D; Walther W
    Methods Mol Biol; 2022; 2521():173-188. PubMed ID: 35732998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in uterine carcinosarcomas.
    Santin AD; Bellone S; Siegel ER; McKenney JK; Thomas M; Roman JJ; Burnett A; Tognon G; Bandiera E; Pecorelli S
    Clin Cancer Res; 2007 Jun; 13(11):3339-46. PubMed ID: 17545541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium.
    Long H; Crean CD; Lee WH; Cummings OW; Gabig TG
    Cancer Res; 2001 Nov; 61(21):7878-81. PubMed ID: 11691807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective Oncoleaking Treatment of Pancreatic Cancer by Claudin-Targeted Suicide Gene Therapy with
    Pahle J; Kobelt D; Aumann J; Behrens D; Daberkow O; Mokritzkij M; Piontek J; Stein U; Walther W
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of an alanine-substituted mutant of the C-terminal fragment of Clostridium perfringens enterotoxin as a mucosal vaccine in mice.
    Suzuki H; Kondoh M; Kakutani H; Yamane S; Uchida H; Hamakubo T; Yagi K
    Biomaterials; 2012 Jan; 33(1):317-24. PubMed ID: 21983135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase Cα inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens enterotoxin via claudin-4.
    Kyuno D; Kojima T; Ito T; Yamaguchi H; Tsujiwaki M; Takasawa A; Murata M; Tanaka S; Hirata K; Sawada N
    Cell Tissue Res; 2011 Dec; 346(3):369-81. PubMed ID: 22160590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bystander Host Cell Killing Effects of Clostridium perfringens Enterotoxin.
    Shrestha A; Hendricks MR; Bomberger JM; McClane BA
    mBio; 2016 Dec; 7(6):. PubMed ID: 27965452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity of Clostridium perfringens enterotoxin depends on the conditions of claudin-4 in ovarian carcinoma cells.
    Tanaka S; Aoyama T; Ogawa M; Takasawa A; Murata M; Osanai M; Saito T; Sawada N
    Exp Cell Res; 2018 Oct; 371(1):278-286. PubMed ID: 30142326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
    Casagrande F; Cocco E; Bellone S; Richter CE; Bellone M; Todeschini P; Siegel E; Varughese J; Arin-Silasi D; Azodi M; Rutherford TJ; Pecorelli S; Schwartz PE; Santin AD
    Cancer; 2011 Dec; 117(24):5519-28. PubMed ID: 21692061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel tumor-targeted therapy using a claudin-4-targeting molecule.
    Saeki R; Kondoh M; Kakutani H; Tsunoda S; Mochizuki Y; Hamakubo T; Tsutsumi Y; Horiguchi Y; Yagi K
    Mol Pharmacol; 2009 Oct; 76(4):918-26. PubMed ID: 19638534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial Toxins for Oncoleaking Suicidal Cancer Gene Therapy.
    Pahle J; Walther W
    Recent Results Cancer Res; 2016; 209():95-110. PubMed ID: 28101690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.